chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Per client 2 days after had shortness of breath, intense headache, numbness to left side of face radiating to torse, and flu-like symptoms. On third day client went to ER where she tested negative for Covid and was prescribed Tramadol. Client states she then followed up with medical provider and was informed of high cholesterol and possible allergy to a component of Pfizer Covid Vaccine. Provider prescribed client Lipitol. Client stated symptoms resolved in 1 week.
Depression - started taking Prozac in May (I'm a school teacher, the constant uncertainty and continual changing rules around teaching took their toll) TMJ locking and pain (may be a side effect of Prozac)
Loss of feeling in right foot and blurred vision on evening of second day after vaccination.  Symptoms developed at same time as fever started.  Fever lasted the evening with bed soaked in sweat then broke by the morning.  Lose of feeling in foot improved by next day and feeling returned entirely after 5 days.  Blurred vision improved by next day but has been lasting one and off for two weeks.  After feeling returned in right foot there was one evening of right ankle cramping.  Finally fasciculations and "pins and needles" feeling happened in the face, right wrist, and right leg happened during the 2nd week after the shot but improved by the third week.
Patient says that after the first shot her post herpetic neuralgia became more severe; Patient says that after the first shot her post herpetic neuralgia became more severe; This non-serious case was reported by a nurse via sales rep and described the occurrence of post herpetic neuralgia in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had shingles(shingles rash) in 2017). Concurrent medical conditions included post herpetic neuralgia.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced post herpetic neuralgia (Verbatim: Patient says that after the first shot her post herpetic neuralgia became more severe) and condition aggravated (Verbatim: Patient says that after the first shot her post herpetic neuralgia became more severe). The outcome of the post herpetic neuralgia and condition aggravated were not reported.   It was unknown if the reporter considered the post herpetic neuralgia and condition aggravated to be related to Shingrix.     It was unknown if the company considered the post herpetic neuralgia and condition aggravated to be related to Shingrix.   Additional Information: GSK Receipt Date: 02-AUG-2023 The patient had shingles and reported on and off post herpetic neuralgia after shingles rash cleared.  The patient recently received first shot of Shingrix and did not had an active rash at time of vaccine, question was asked and reporter said no. The patient said that after the first shot her post herpetic neuralgia became more severe. The reporter asked if this was caused by the vaccine and wondered if it was ok for patient to receive the second shot. The reporter did not agree to follow up from GlaxoSmithKline (GSK).
COVID-19 admission screen to ER dept was positive. She presented to the emergency department after a fall at the nursing home she resides in.  She slipped getting out of bed and hit her head while putting her shoes on.  A syncopal episode followed.
Severe fever, hallucinations (fever dreams) lasted hours, sweating, weakness, shaking.
On May 14 at School, patient was administered four times the correct dose of inactivated polio virus. The patient was monitored for 5 mins to check for reaction, and none were present.  I realized that the dosage was wrong while logging the vaccine into the system. Immediately  I let provider, know of the error and she spoke to, patient's mother. We told her that he was administered more of the vaccination than he should have received. She was calm and just asked us what she should watch for. They were asked to stay in order for us to watch the patient to see if he had any adverse reaction to the vaccine. They left about half an hour after. I let them know we would be calling the CDC and poison control to get any instructions from them, and also know how to guide her in his care. Provider contacted the CDC and I contacted Poison Control, we both got back the same responses. The patient should be fine, the higher dosage of polio should only increase the risk of the regular vaccine symptoms such as fever, vomiting, bruising and soreness at the site, and child irritability. After receiving the information I contacted the mother and let her know, we also gave her our on call phone number in case she had any questions or concerns. The mother verbalized understanding.
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: Patient's arm was swollen, red to the touch, itchy, patient states it started the day of vaccine administration and progressivley got worse. Looks like cellulitis.
patient received expired vaccine; Product Storage error; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received expired vaccine) and PRODUCT STORAGE ERROR (Product Storage error) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received expired vaccine) and PRODUCT STORAGE ERROR (Product Storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received expired vaccine) and PRODUCT STORAGE ERROR (Product Storage error) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Product moved from freezer to fridge on 06-MAY-2022. Treatment details was not reported by the reporter.
2 hours, post vax, the pt developed 3 episodes of clonic movement of the right arm and right leg X 15 seconds with 5 minute spacing between episodes. No loss of consciousness. He seemed normal 20 minutes later. Exam done within 24 hours. No focal deficits. Neurologist's exam was normal.
Patient reported shoulder and back pains a few days after receiving the vaccine. She took some OTC painkillers, which did not help much. She reported she continues to have pain in the back when she came in for her second shot.
Insomnia; hyponatremia; stomach pain; sweaty palms; nerve pain (especially in vagus nerve); electric bolts; migraines; back pain; throat pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Sep2022 at 14:00 as dose 4 (booster), single (Lot number: GH9703) at the age of 47 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included: Cephalosporins, reaction(s): "Allergy". Vaccination history included: Covid-19 vaccine (DOSE 1, UNKNOWN MANUFACTURER), for COVID-19 immunization; Covid-19 vaccine (DOSE 2, UNKNOWN MANUFACTURER), for COVID-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER), UNKNOWN MANUFACTURER), for COVID-19 immunization. The following information was reported: INSOMNIA (hospitalization) with onset 29Sep2022, outcome "not recovered"; BACK PAIN (hospitalization) with onset 29Sep2022, outcome "not recovered"; ELECTRIC SHOCK (hospitalization) with onset 29Sep2022, outcome "not recovered", described as "electric bolts"; HYPONATRAEMIA (hospitalization) with onset 29Sep2022, outcome "not recovered", described as "hyponatremia"; MIGRAINE (hospitalization) with onset 29Sep2022, outcome "not recovered", described as "migraines"; NEURALGIA (hospitalization) with onset 29Sep2022, outcome "not recovered", described as "nerve pain (especially in vagus nerve)"; ABDOMINAL PAIN UPPER (hospitalization) with onset 29Sep2022, outcome "not recovered", described as "stomach pain"; HYPERHIDROSIS (hospitalization) with onset 29Sep2022, outcome "not recovered", described as "sweaty palms"; OROPHARYNGEAL PAIN (hospitalization) with onset 29Sep2022, outcome "not recovered", described as "throat pain". The patient was hospitalized for insomnia, hyponatraemia, abdominal pain upper, hyperhidrosis, neuralgia, electric shock, migraine, back pain, oropharyngeal pain (hospitalization duration: 1 day(s)). The events "insomnia", "hyponatremia", "stomach pain", "sweaty palms", "nerve pain (especially in vagus nerve)", "electric bolts", "migraines", "back pain" and "throat pain" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (09Oct2022) Negative, notes: Nasal Swab. Therapeutic measures IV (intraveneous) saline, gabapentin, melatonin, protonix were taken as a result of insomnia, hyponatraemia, abdominal pain upper, hyperhidrosis, neuralgia, electric shock, migraine, back pain, oropharyngeal pain.
To ER 6/26 - Lymphadenitis, fever - placed on CIPRO. To clinic 6/27 - Rt lymphadenopathy, fever.
pt exp hives 5/14/99 then spread to abd, hands feet swollen 5/15 & 5/16. resolved 5/17/99 then hives reappeared  5/18 in eve then by morn 5/19 started again. pt consulted md for evaluation
11/15/06 Case received flu/PNEUMOVAX shot at public clinic. 11/17/06 Right arm sore, area of site red, hot to touch, fever 102, seen in ER and given Prednisone for 3 days, antibiotic for 10 days. Dx Cellulitis. Advised to put compress on site. 11/22/06 Case reported to 30 hours in person - states arm was much better.
I had a red and hard spot after the vaccine that kept getting bigger. I was seen by my primary care doctor, sent pictures to my dermatologist, and went to the Emergency room. The spot was ichy and painful. There was a bruise of different colors. It was spreading and I am going back to the Doctor today. I am on antibiotics for 10 days, taking this doxycycline pill two times daily. Furthermore, every 6 hours I have been taking benadryl and applying ice.
Child developed a large (softball-sized) ring of erythema, warmth and swelling around vaccination site.
Patient states had a sore arm, hard to lift the day of the vaccine, then returned to pharmacy on 7/23/17 with a red, swollen, sore arm. Pharmacist recommended she take BENADRYL and see her provider if symptoms worsened or did not improve. Called patient 7/24/17, patient states much better today, still not feeling great, but swelling and redness are much better. She had an appointment with her provider on Thursday. Pharmacist sent information on vaccine reaction to her provider.
I had a sore arm. I had a red spot. I had a running nose, cough, and chills. My arm was sore and red. On Tuesday, I had sinus pain. I called my provider. They wanted me to take a COVID-19 test, negative results. I am on day 7 and I still have the cough and running nose.
Started having dizzies spells, when they move their head, like if they are reading and move head around, or when they laid down at night and head hit the pillow at night.; Dizzy spells/still dealing with the dizziness; She feels out of sort; Few seconds of room just swirls around/room begins to swirl It does not last long but its not comfortable.; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (Started having dizzies spells, when they move their head, like if they are reading and move head around, or when they laid down at night and head hit the pillow at night.), FEELING ABNORMAL (She feels out of sort), VERTIGO (Few seconds of room just swirls around/room begins to swirl It does not last long but its not comfortable.) and DIZZINESS (Dizzy spells/still dealing with the dizziness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039F21A, 001B21A and 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced FEELING ABNORMAL (She feels out of sort) and VERTIGO (Few seconds of room just swirls around/room begins to swirl It does not last long but its not comfortable.). On 17-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEAD DISCOMFORT (Started having dizzies spells, when they move their head, like if they are reading and move head around, or when they laid down at night and head hit the pillow at night.) and DIZZINESS (Dizzy spells/still dealing with the dizziness). At the time of the report, HEAD DISCOMFORT (Started having dizzies spells, when they move their head, like if they are reading and move head around, or when they laid down at night and head hit the pillow at night.), FEELING ABNORMAL (She feels out of sort) and VERTIGO (Few seconds of room just swirls around/room begins to swirl It does not last long but its not comfortable.) outcome was unknown and DIZZINESS (Dizzy spells/still dealing with the dizziness) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided. It was reported that the patient has few seconds of the room just swirls around. When she goes to lay down at night and leaning back, the room begins to swirl. It does not last long, but it was not comfortable.   This case was linked to MOD-2021-400104.   Most recent FOLLOW-UP information incorporated above includes: On 29-Nov-2021: Follow up information received included patient demographics, reporter details and new events were added.
Pt recv vax on 3/16/99; on 3/23/99 pt exp fussiness, fever (104)     <24 hr, measles-like rash over body
No adverse effect; Patient received Gardasil 9 1st dose on 01-JUN-2016 and 2nd dose on 08-AUG-2017; This spontaneous report as received from a Medical Assistant referring to a 13-year-old female patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications.    On 01-JUN-2019, when the patient was 11 years old, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis (dose, route of administration, lot number and expiration date were not reported).  On 08-AUG-2017, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis (dose, route of administration, lot number and expiration date were not reported) "slightly delayed". No adverse effect was reported. No additional doses were administered.  At the time of the report, the patient's outcome was unknown.
1 month after vaccine started w/pain at injection site, radiating down arm.  Weakness and pain to left hand/wrist w/swelling.  Weakness affecting grip and function.
Child received two doses of the 2017-18 flu vaccine after receiving two doses last year for the 2016-17 vaccine. He should have only received one but was inadvertently given two.
pretty bad Pressure in her chest; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (pretty bad Pressure in her chest) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 14M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Asthma, Diabetes and Allergy.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced CHEST DISCOMFORT (pretty bad Pressure in her chest). At the time of the report, CHEST DISCOMFORT (pretty bad Pressure in her chest) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications blood pressure medications, asthma medications, sugar shots and allergy medicine. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Updated re-challenge field.
chills, weakness Narrative: Per nursing report: 2nd shot 4/7/2021-chills, weakness"
Shot given 8/19/09 -Weds- Onset of soreness/hot to the touch-FRIDAY-SATURDAY-8/21-22.  Saw patient- 8/24/09- Monday-Small knot in muscle-slight redness and tenderness.  Pt states it is going away.
Initial report received from a health care professional on 28 October 2011. A 75-year-old male patient received an intramuscular injection (site not reported) of FLUZONE No Preservative 2011-2012, lot number UT443AA, on 07 October 2011. The patient had a history of hypertension, stroke in 2009, hip replacement, and lung cancer. He had no adverse events following prior administration of vaccines and had no other vaccinations within 4 weeks of the FLUZONE. The patient's concomitant medications included NEURONTIN, atenolol, 'AGRINOX", terazosin and vitamins. The patient was in the hospital rehabilitation department for a complete physical and received the FLUZONE vaccine. A few days later he was transferred to the Intensive Care Unit (ICU). The patient was lethargic for ten days, could hardly keep his eyes open and was incontinent. The patient had a computed tomography scan, chest x-ray, blood work, cultures and a swallow test which were all negative. The outcome was reported as not recovered (improving). Documents held by sender: None.
With both shots (first one in July 2019) after 24 hours I felt like I was hit by a truck - flu-like symptoms, body aches, exhaustion, couldn't stay warm - slept for 12-16 hours.  Side effect lasted for about 18 hours.  Fine the following day.
A few minutes after injection, pt states not feeling well, pt becomes non responsive with jerking movements x 2 approx 1-2 minutes pt began to respond to nurse-cold cloth to face and neck B/P assessed 90/64. EMT called assessed pt pt refuses transfer to hospital ER via ambulance. Family member called to pick up pt. States pt has had same reaction before when receiving an injection.
Flaking skin; Arthritis aggravated symptoms overall/ hips, shoulders; Psoriasis developing on the scalp; Weakness in extremity/Weakness in the hands, forearms; This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (Flaking skin), ARTHRITIS (Arthritis aggravated symptoms overall/ hips, shoulders), PSORIASIS (Psoriasis developing on the scalp) and MUSCULAR WEAKNESS (Weakness in extremity/Weakness in the hands, forearms) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced SKIN EXFOLIATION (Flaking skin), ARTHRITIS (Arthritis aggravated symptoms overall/ hips, shoulders), PSORIASIS (Psoriasis developing on the scalp) and MUSCULAR WEAKNESS (Weakness in extremity/Weakness in the hands, forearms). At the time of the report, SKIN EXFOLIATION (Flaking skin) and PSORIASIS (Psoriasis developing on the scalp) was resolving, ARTHRITIS (Arthritis aggravated symptoms overall/ hips, shoulders) had not resolved and MUSCULAR WEAKNESS (Weakness in extremity/Weakness in the hands, forearms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No concomitant medication information was provided.  Primary reporter contact for lot number information was unsuccessful.   The reporter's causality for the event(s) of FLAKY SKIN, PSORIASIS DEVELOPING ON THE SCALP and WEAKNESS IN THE HANDS, FOREARMS was not provided. The reporter's causality for the event(s) of INCREASED ARTHRITIS SYMPTOMS OVERALL/HIPS, SHOULDERS with HUMIRA(ADALIMUMAB) was no reasonable possibility.  No treatment medication information was provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Breakthrough case admission/patient expired Pfizer 3/17/21 lot# ER2613;  Pfizer 4/7/21 Lot# EW0150; Pfizer 1/12/22 Pfizer FF2590
Patient was feeling heat and swelling at injection site for more than 5 days- pain became unbearable on 10/05 so she visited the clinic on 10/05 and was prescribed an antibiotic for possible Cellulitis
A non-serious spontaneous report of received expired FLUMIST was received from a health professional concerning a 37-month-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 05-Feb-2012. On 09-Feb-2012, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. The reporter stated that the patient did not experience any late occurring adverse events. This case will be submitted in accordance with MedImmune's FLUMIST post-marketing commitment for the indicated population of 2 years to 59 months of age.
Exhaustion, fever/chills, upset stomach, headache - may have triggered fib - afib led to ICU on 4/22/2021.
Bit of tightness in chest; Soreness in her arm at site; This is a spontaneous report received from a contactable consumer or other non hcp. A female patient of an unspecified age received 1st dose of bnt162b2 (COMIRNATY,Batch/Lot number was not reported), via an unspecified route of administration on 29Jan2021 as Dose 1,single for covid-19 immunization.treprostinil sodium (TYVASO), via an unspecified route of administration from 26Mar2020 (Batch/Lot number was not reported) to an unspecified date, at unspecified dose, via an unspecified route of administration from an unspecified date (Batch/Lot Number: 2101898; Expiration Date: 31Oct2021) and ongoing, at UNK ug, 4x/day (18-54 mcg (3-9 breaths) for pulmonary arterial hypertension.Medical history included ongoing pulmonary arterial hypertension. Concomitant medication(s) included sildenafil citrate and ambrisentan (LETAIRIS) taken for an unspecified indication, start and stop date were not reported.The patient experienced bit of tightness in chest and soreness in her arm at vaccination site on 2021.On 19Feb2021, the following updates were made in the case with Day zero, 11Feb2021: This correction is being submitted to structure COVID vaccine as a co-suspect Product and to update the action taken with COVID vaccine from not reported to not applicable. Information about lot/batch number has been requested. Follow-up (19May2021): Follow-up attempts completed. No further information is expected.